Genetically modified virus for oral squamous cell carcinoma therapeutics

•Preclinical-stage detection is very critical for reducing mortality from OSCC.•Recently Genetically modified (GM) virus therapy have supported to control OSCC.•It reaches tumor sites by the specific multiple signaling pathways and killed OSCC.•GM virus can be delivered immune boosting agents to tumor microenvironment.